Welcome to LookChem.com Sign In|Join Free

CAS

  • or

874784-14-2

2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID is a chemical compound with the molecular formula C7H5BrFNO2, belonging to the benzoic acid derivatives. It is characterized by the presence of an amino group, a bromine atom, and a fluorine atom on the benzoic acid backbone, which endows it with unique chemical properties and reactivity. 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID can be synthesized through various chemical reactions and serves as a versatile building block in the preparation of pharmaceutical and agrochemical products. Furthermore, it is also utilized as a research chemical for studying the reactions and properties of benzoic acid derivatives.

874784-14-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 874784-14-2 Structure

  • Basic information

    1. Product Name: 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID
    2. Synonyms: BUTTPARK 51\07-22;2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID
    3. CAS NO:874784-14-2
    4. Molecular Formula: C7H5BrFNO2
    5. Molecular Weight: 234.02
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 874784-14-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 321.7±42.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.877±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 4.21±0.10(Predicted)
    10. CAS DataBase Reference: 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID(874784-14-2)
    12. EPA Substance Registry System: 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID(874784-14-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 874784-14-2(Hazardous Substances Data)

874784-14-2 Usage

Uses

Used in Organic Synthesis:
2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID is used as a key intermediate in organic synthesis for the preparation of various chemical compounds. Its unique functional groups allow for a wide range of chemical reactions, making it a valuable building block in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID is used as a starting material for the development of new drugs. Its unique structure and reactivity enable the design and synthesis of novel pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Industry:
2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID is also utilized in the agrochemical industry for the synthesis of various agrochemical products, such as pesticides and herbicides. Its unique chemical properties make it a valuable component in the development of effective and environmentally friendly agrochemicals.
Used as a Research Chemical:
2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID serves as a research chemical for studying the reactions and properties of benzoic acid derivatives. It provides valuable insights into the reactivity and behavior of these compounds, contributing to the advancement of organic chemistry and the development of new synthetic methods and applications.

Check Digit Verification of cas no

The CAS Registry Mumber 874784-14-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,7,8 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 874784-14:
(8*8)+(7*7)+(6*4)+(5*7)+(4*8)+(3*4)+(2*1)+(1*4)=222
222 % 10 = 2
So 874784-14-2 is a valid CAS Registry Number.

874784-14-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Amino-5-bromo-3-fluorobenzoic acid

1.2 Other means of identification

Product number -
Other names 5-bromo-3-ethoxypyrazine-2-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:874784-14-2 SDS

874784-14-2Upstream product

874784-14-2Relevant articles and documents

DIARYLTHIOHYDANTOIN COMPOUND AS ANDROGEN RECEPTOR ANTAGONIST

-

Paragraph 0271-0273, (2020/07/07)

The present application belongs to the field of medicine. In particular, the present application relates to a diarylthiohydantoin compound as an androgen receptor antagonist or a pharmaceutically acceptable salt thereof, a preparation method of the same, a pharmaceutical composition comprising the compound, and a use thereof in treating a cell proliferative disease mediated by androgen. The compound of the present application has good antagonistic effect on androgen receptor and exhibits excellent antitumor effect.

TREATMENT OF FIBROSIS WITH IRE1 SMALL MOLECULE INHIBITORS

-

Paragraph 00330, (2020/11/30)

Provided herein are methods of using IRE1 small molecule inhibitors in combination therapies for treating fibrosis in a subject. The IRE1 small molecule inhibitors described herein may be used in combination therapies for treating fibrosis

Quinazolinone Compound and Application Thereof

-

Paragraph 0498-0500, (2020/11/27)

The present invention relates to a series of quinazolinone compounds and applications thereof as PI3Kα inhibitors. In particular, the present invention relates to a compound shown in formula (I) and a tautomer or pharmaceutically acceptable salt thereof.

NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES

-

Page/Page column 50, (2020/12/07)

The present invention relates to Compounds of Formula I: I and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Fo

COMBINATION THERAPIES WITH IRE1 SMALL MOLECULE INHIBITORS

-

Paragraph 00354, (2020/12/01)

Provided herein are methods of using IRE1 small molecule inhibitors in combination therapies for treating cancer in a subject. The IRE1 small molecule inhibitors described herein may be used in combination therapies for treating solid and hematologic cancers.

IRE1 SMALL MOLECULE INHIBITORS

-

Paragraph 00390, (2019/05/30)

Provided herein are small molecule inhibitors for the targeting or IRE1 protein family members. Binding may be direct or indirect. Further provided herein are methods of using IRE1 small molecule inhibitors for use in treating or ameliorating cancer in a subject. Moreover, IRE1 small molecule inhibitors described herein are for the treatment of cancer, where the cancer is a solid or hematologic cancer.

CARBAMATE QUINABACTIN

-

Paragraph 0153; 0154, (2018/02/23)

The present invention relates to novel sulfonamide derivatives, to processes and intermediates for preparing them, to plant growth regulator compositions comprising them and to methods of using them for controlling the growth of plants, improving plant tolerance to abiotic stress (including environmental and chemical stresses), inhibiting seed germination and/or safening a plant against phytotoxic effects of chemicals.

KAPPA OPIOID RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO

-

Page/Page column 96; 170; 171, (2018/10/19)

Compounds are provided that antagonize the kappa-opioid receptor (KOR) and products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope or salt thereof: (I) wherein X, Y, R1, R2, R4, R5 R6, R7, R8 and R11 are as defined herein.

2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER

-

Page/Page column 212, (2017/10/11)

The invention relates to novel compounds of formula I which are inhibitors of deubiquitylating enzymes (DUBs) and/or desumoylating enzymes. In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 7 or ubiquitin specific peptidase 7 (USP7). The invention further relates to methods for the preparation of these compounds and to their use in the treatment of cancer.

SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1

-

Paragraph 00535, (2016/04/26)

Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 874784-14-2